TITLE

Fractional Flow Reserve-Guided PCI versus Medical Therapy in Stable Coronary Disease

AUTHOR(S)
De Bruyne, Bernard; Pijls, Nico H.J.; Kalesan, Bindu; Barbato, Emanuele; Tonino, Pim A.L.; Piroth, Zsolt; Jagic, Nikola; Mobius-Winckler, Sven; Rioufol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engstr�m, Thomas; Oldroyd, Keith G.; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B.
PUB. DATE
September 2012
SOURCE
New England Journal of Medicine;9/13/2012, Vol. 367 Issue 11, p991
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The preferred initial treatment for patients with stable coronary artery disease is the best available medical therapy. We hypothesized that in patients with functionally significant stenoses, as determined by measurement of fractional flow reserve (FFR), percutaneous coronary intervention (PCI) plus the best available medical therapy would be superior to the best available medical therapy alone. Methods: In patients with stable coronary artery disease for whom PCI was being considered, we assessed all stenoses by measuring FFR. Patients in whom at least one stenosis was functionally significant (FFR, =0.80) were randomly assigned to FFR-guided PCI plus the best available medical therapy (PCI group) or the best available medical therapy alone (medical-therapy group). Patients in whom all stenoses had an FFR of more than 0.80 were entered into a registry and received the best available medical therapy. The primary end point was a composite of death, myocardial infarction, or urgent revascularization. Results: Recruitment was halted prematurely after enrollment of 1220 patients (888 who underwent randomization and 332 enrolled in the registry) because of a significant between-group difference in the percentage of patients who had a primary end-point event: 4.3% in the PCI group and 12.7% in the medical-therapy group (hazard ratio with PCI, 0.32; 95% confidence interval [CI], 0.19 to 0.53; P<0.001). The difference was driven by a lower rate of urgent revascularization in the PCI group than in the medical-therapy group (1.6% vs. 11.1%; hazard ratio, 0.13; 95% CI, 0.06 to 0.30; P<0.001); in particular, in the PCI group, fewer urgent revascularizations were triggered by a myocardial infarction or evidence of ischemia on electrocardiography (hazard ratio, 0.13; 95% CI, 0.04 to 0.43; P<0.001). Among patients in the registry, 3.0% had a primary end-point event. Conclusions: In patients with stable coronary artery disease and functionally significant stenoses, FFR-guided PCI plus the best available medical therapy, as compared with the best available medical therapy alone, decreased the need for urgent revascularization. In patients without ischemia, the outcome appeared to be favorable with the best available medical therapy alone. (Funded by St. Jude Medical; ClinicalTrials.gov number, NCT01132495.)
ACCESSION #
79820608

 

Related Articles

  • 2014 ESC/EACTS Guidelines on myocardial revascularization. Kolh, Philippe; Windecker, Stephan; Alfonso, Fernando; Collet, Jean-Philippe; Cremer, Jochen; Falk, Volkmar; Filippatos, Gerasimos; Hamm, Christian; Head, Stuart J.; Jüni, Peter; Kappetein, A. Pieter; Kastrati, Adnan; Knuuti, Juhani; Landmesser, Ulf; Laufer, Günther; Neumann, Franz-Josef; Richter, Dimitrios J.; Schauerte, Patrick; Sousa Uva, Miguel; Stefanini, Giulio G. // European Journal of Cardio-Thoracic Surgery;Oct2014, Vol. 46 Issue 4, p517 

    The article presents the European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EASC) guidelines on myocardial revascularization therapy post-SYNTAX. Featured in the guidelines are the approach to calculate the SYNTAX score and the risk models to assess outcomes as...

  • Diagnosis and treatment of acquired coronary artery disease in adults. Wilson, J. M. // Postgraduate Medical Journal;Jul2009, Vol. 85 Issue 1005, p7 

    Coronary artery disease evolves, often unnoticed, over decades, often culminating in myocardial infarction. Metabolic and behavioural risk factors affect the development and progression of atherosclerotic lesions. The diagnosis may be arrived at clinically but typically involves confirmatory and...

  • Use and Overuse of Angiography and Revascularization for Acute Coronary Syndromes. Lange, Richard A.; Hillis, L. David // New England Journal of Medicine;06/18/98, Vol. 338 Issue 25, p1838 

    Editorial. Questions the overuse of angiography and revascularization as treatments for acute coronary syndromes. Factors influencing the trend of these procedures.

  • Revascularisation for patients with stable coronary artery disease: CABG and contemporary PCI can both reduce mortality. Ziada, Khaled; Moliterno, David J. // BMJ: British Medical Journal;7/5/2014, Vol. 348 Issue 7965, pg4099 

    The author reflects on the evidence that percutaneous coronary interventions (PCI) reduce the risk of myocardial infarction and death in patients with acute coronary syndromes but these benefits have not been established for patients with stable coronary artery disease. Topics discussed include...

  • Transmyocardial revascularization. Hayden, Ann Marie; Moore, Kathleen // RN;May98, Vol. 61 Issue 5, p44 

    Presents information on the transmyocardial revascularization (TMR) technique to be used in the treatment of coronary artery disease. In-depth at the TMR technique; Criteria for treatment with the TMR technique; Information on a study involving TMR patients.

  • Prognostic value of coronary multidetector CT angiography in patients with an intermediate probability of significant coronary heart disease. Hay, C. S. M.; Morse, R. J.; Morgan-Hughes, G. J.; Gosling, O.; Shaw, S. R.; Roobottom, C. A. // British Journal of Radiology;Apr2010, Vol. 83 Issue 988, p327 

    The aim of this study was to determine the prognostic value of coronary multidetector CT angiography (MDCTA) in patients with an intermediate pre-test probability of significant coronary artery disease (CAD). Patients who underwent 64- slice coronary MDCTA and met the selection criteria were...

  • Percutaneous Intervention vs. Coronary-Artery Bypass Grafting in Left Main Coronary Disease. Jones, Robert H. // New England Journal of Medicine;4/24/2008, Vol. 358 Issue 17, p1851 

    The author reflects on the issue of the use of percutaneous intervention and coronary artery bypass grafting in the treatment of left main coronary disease. He suggests that implanted stents and bypass conduits may over time become more of a disease than a treatment. He argues that continued...

  • Guidelines on the management of stable coronary artery disease. Linden, Belinda // British Journal of Cardiac Nursing;Nov2013, Vol. 8 Issue 11, p519 

    The article presents an overview of the guidelines recently published by the European Society of Cardiology for the management of stable coronary artery disease. It explains the role of diagnostic testing and prognostic assessment. It relates the discussion of the role of coronary...

  • Revaskularizacija miokarda bez primene vantelesnog krvotoka. Milojević, P. S. // Acta Chirurgica Iugoslavica;2008, Vol. 55 Issue 1, p33 

    Contemporary treatment of coronary disease includes: drug treatment, percutaneous coronary angioplasty (PCI), with or without stent implantation and surgical myocardial revasculanzation. For more than 30 years, conventional coronary bypass (on-pump CABO), using cardiopulmonary bypass (CPB),...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics